Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5197841
Max Phase: Preclinical
Molecular Formula: C18H26N2O4S
Molecular Weight: 366.48
Associated Items:
ID: ALA5197841
Max Phase: Preclinical
Molecular Formula: C18H26N2O4S
Molecular Weight: 366.48
Associated Items:
Canonical SMILES: CCOC1CCCCC1NC(=O)c1ccccc1NS(=O)(=O)C1CC1
Standard InChI: InChI=1S/C18H26N2O4S/c1-2-24-17-10-6-5-9-16(17)19-18(21)14-7-3-4-8-15(14)20-25(22,23)13-11-12-13/h3-4,7-8,13,16-17,20H,2,5-6,9-12H2,1H3,(H,19,21)
Standard InChI Key: ORYGXVWOIQUNCH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 366.48 | Molecular Weight (Monoisotopic): 366.1613 | AlogP: 2.67 | #Rotatable Bonds: 7 |
Polar Surface Area: 84.50 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 5.41 | CX Basic pKa: | CX LogP: 1.91 | CX LogD: 1.00 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.78 | Np Likeness Score: -1.08 |
1. Sharma S, Peng Q, Vadukoot AK, Aretz CD, Jensen AA, Wallick AI, Dong X, Hopkins CR.. (2022) Synthesis and Biological Characterization of a Series of 2-Sulfonamidebenzamides as Allosteric Modulators of MrgX1., 13 (5.0): [PMID:35586421] [10.1021/acsmedchemlett.2c00100] |
Source(1):